Odyssey Health Inc Financials
This page shows Odyssey Health Inc (ODYY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Odyssey Health Inc passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Odyssey Health Inc generates $0.20 in operating cash flow (-$347K OCF vs -$1.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Odyssey Health Inc earns $-4.0 in operating income for every $1 of interest expense (-$1.0M vs $253K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Odyssey Health Inc reported -$1.7M in net income in fiscal year 2025. This represents a decrease of 106.9% from the prior year.
Odyssey Health Inc earned $-0.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Odyssey Health Inc held $26K in cash against $0 in long-term debt as of fiscal year 2025.
Odyssey Health Inc had 100M shares outstanding in fiscal year 2025. This represents an increase of 3.3% from the prior year.
Odyssey Health Inc invested $0 in research and development in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
ODYY Income Statement
| Metric | Q1'25 | Q3'25 | Q1'24 | Q2'24 | Q3'24 | Q3'23 | Q2'23 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $0 | $0 | N/A | $0-100.0% | $23K | N/A | $461K |
| SG&A Expenses | $303K+158.5% | $117K-79.8% | $579K | N/A | $321K-36.0% | $501K | N/A | $944K |
| Operating Income | -$303K-134.9% | -$129K+77.7% | -$579K | N/A | -$372K-7.2% | -$347K | N/A | -$2.1M |
| Interest Expense | $95K+55.3% | $61K-10.7% | $69K | N/A | $102K-46.4% | $191K | N/A | $71K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$483K-92.0% | -$252K+75.3% | -$1.0M | N/A | -$842K-56.6% | -$538K | N/A | -$2.1M |
| EPS (Diluted) | $0.00 | $0.00+100.0% | $-0.01 | N/A | $-0.010.0% | $-0.01 | N/A | $-0.03 |
ODYY Balance Sheet
| Metric | Q1'25 | Q3'25 | Q1'24 | Q2'24 | Q3'24 | Q3'23 | Q2'23 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $144K-12.7% | $165K-51.8% | $341K-41.8% | $586K-95.7% | $13.6M+2118.1% | $612K+34.3% | $456K-47.5% | $868K |
| Current Assets | $144K+113.2% | $67K-63.1% | $183K+220.6% | $57K-62.9% | $153K-72.8% | $563K+38.7% | $406K-50.3% | $817K |
| Cash & Equivalents | $26K+703.1% | $3K-94.1% | $54K+2164.2% | $2K-96.4% | $66K-66.6% | $198K+436.8% | $37K-27.0% | $50K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $7.3M+6.3% | $6.9M+3.7% | $6.6M+11.8% | $5.9M+3.9% | $5.7M-16.6% | $6.8M+3.3% | $6.6M+5.8% | $6.3M |
| Current Liabilities | $7.3M+6.3% | $6.9M+3.7% | $6.6M+11.8% | $5.9M+3.9% | $5.7M-16.6% | $6.8M+3.3% | $6.6M+5.8% | $6.3M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$7.2M-6.7% | -$6.7M-6.8% | -$6.3M-17.7% | -$5.3M-167.7% | $7.9M+226.7% | -$6.2M-1.0% | -$6.2M-14.3% | -$5.4M |
| Retained Earnings | -$63.2M-1.2% | -$62.5M-0.8% | -$62.0M-1.7% | -$61.0M-26.4% | -$48.3M+20.4% | -$60.6M-0.9% | -$60.1M-6.7% | -$56.3M |
ODYY Cash Flow Statement
| Metric | Q1'25 | Q3'25 | Q1'24 | Q2'24 | Q3'24 | Q3'23 | Q2'23 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$284K-6998.2% | -$4K+98.4% | -$249K-290.5% | -$64K+65.4% | -$184K-207.4% | -$60K+50.0% | -$120K+57.9% | -$285K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $8K |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$293K |
| Investing Cash Flow | $70K | $0 | N/A | $0 | $0 | $0+100.0% | -$2K+74.8% | -$8K |
| Financing Cash Flow | $291K | $0-100.0% | $300K | $0-100.0% | $84K-62.0% | $221K+40.3% | $158K-41.8% | $271K |
| Dividends Paid | N/A | $0 | N/A | N/A | $0 | $0 | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
ODYY Financial Ratios
| Metric | Q1'25 | Q3'25 | Q1'24 | Q2'24 | Q3'24 | Q3'23 | Q2'23 | Q3'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | 153.1% | N/A | N/A | N/A |
| Return on Assets | -336.6%-183.6pp | -153.0%+145.7pp | -298.8% | N/A | -6.2%+81.7pp | -87.9% | N/A | -247.7% |
| Current Ratio | 0.020.0 | 0.01-0.0 | 0.03+0.0 | 0.01-0.0 | 0.03-0.1 | 0.08+0.0 | 0.06-0.1 | 0.13 |
| Debt-to-Equity | -1.020.0 | -1.02+0.0 | -1.05+0.1 | -1.11-1.8 | 0.72+1.8 | -1.10-0.0 | -1.07+0.1 | -1.16 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$7.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Odyssey Health Inc profitable?
No, Odyssey Health Inc (ODYY) reported a net income of -$1.7M in fiscal year 2025.
What is Odyssey Health Inc's earnings per share (EPS)?
Odyssey Health Inc (ODYY) reported diluted earnings per share of $-0.02 for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Odyssey Health Inc's operating cash flow?
Odyssey Health Inc (ODYY) generated -$347K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Odyssey Health Inc's total assets?
Odyssey Health Inc (ODYY) had $144K in total assets as of fiscal year 2025, including both current and long-term assets.
How many shares does Odyssey Health Inc have outstanding?
Odyssey Health Inc (ODYY) had 100M shares outstanding as of fiscal year 2025.
What is Odyssey Health Inc's current ratio?
Odyssey Health Inc (ODYY) had a current ratio of 0.02 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Odyssey Health Inc's debt-to-equity ratio?
Odyssey Health Inc (ODYY) had a debt-to-equity ratio of -1.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Odyssey Health Inc's return on assets (ROA)?
Odyssey Health Inc (ODYY) had a return on assets of -1213.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Odyssey Health Inc's cash runway?
Based on fiscal year 2025 data, Odyssey Health Inc (ODYY) had $26K in cash against an annual operating cash burn of $347K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Odyssey Health Inc's debt-to-equity ratio negative or unusual?
Odyssey Health Inc (ODYY) has negative shareholder equity of -$7.2M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Odyssey Health Inc's Piotroski F-Score?
Odyssey Health Inc (ODYY) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Odyssey Health Inc's earnings high quality?
Odyssey Health Inc (ODYY) has an earnings quality ratio of 0.20x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Odyssey Health Inc cover its interest payments?
Odyssey Health Inc (ODYY) has an interest coverage ratio of -4.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.